Issued Patents All Time
Showing 26–50 of 96 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11034757 | Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2021-06-15 |
| 10954291 | Monoclonal antibodies that specifically bind to matrilin-3 and their use | Jeffrey Baron, Crystal Sao Fong Cheung, Julian Chun Kin Lui, Zhongyu Zhu | 2021-03-23 |
| 10934360 | Human monoclonal antibodies against EPHA4 and their use | Nancy Yuk-Yu Ip, Kit Yu Fu, Wing Yu Fu, Tianlei Ying | 2021-03-02 |
| 10844128 | Compositions and methods for treating cancer with anti-CD123 immunotherapy | Rimas J. Orentas, Dina Schneider, Boro Dropulic, Zhongyu Zhu | 2020-11-24 |
| 10822379 | Molecules that bind to SARS-CoV-2 | Chuan-Mu Chen, Dontcho V. Jelev, John W. Mellors, Wei Li, Zehua Sun | 2020-11-03 |
| 10799584 | Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2020-10-13 |
| 10758526 | Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2020-09-01 |
| 10758614 | Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2020-09-01 |
| 10758613 | Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2020-09-01 |
| 10730941 | Antigen-binding proteins targeting CD56 and uses thereof | Michel Sadelain, Reuben Benjamin, Yang Feng | 2020-08-04 |
| 10703816 | M971 chimeric antigen receptors | Rimas J. Orentas, Ira H. Pastan, Crystal L. Mackall | 2020-07-07 |
| 10647754 | Stabilized single human CD4 domains and fusion proteins | Weizao Chen, Prabakaran Ponraj | 2020-05-12 |
| 10640571 | Human monoclonal antibodies specific for glypican-3 and use thereof | Mitchell Ho, Mingqian Feng, Wei Gao | 2020-05-05 |
| 10633441 | Mesothelin-targeted chimeric antigen receptors and uses thereof | Prasad S. Adusumilli, Michel Sadelain, Yang Feng | 2020-04-28 |
| 10633447 | Soluble engineered monomeric Fc | Tianlei Ying | 2020-04-28 |
| 10604582 | Anti-CD276 antibodies (B7H3) | Zhongyu Zhu, Bradley St. Croix, Steven Seaman, Saurabh Saha, Xiaoyan Zhang +2 more | 2020-03-31 |
| 10604583 | Anti-CD276 polypeptides, proteins, and chimeric antigen receptors | Rimas J. Orentas, Zhongyu Zhu, Crystal L. Mackall, Bradley St. Croix, Saurabh Saha | 2020-03-31 |
| 10548987 | Antibody-drug conjugates for targeting CD56-positive tumors | Yang Feng, John Maris, Zhongyu Zhu, Robyn Tovah Sussman | 2020-02-04 |
| 10550179 | Compositions and methods for treating cancer with anti-mesothelin immunotherapy | Rimas J. Orentas, Dina Schneider, Boro Dropulic, Zhongyu Zhu | 2020-02-04 |
| 10543263 | Compositions and methods for treating cancer with anti-CD22 immunotherapy | Rimas J. Orentas, Dina Schneider, Boro Dropulic, Zhongyu Zhu | 2020-01-28 |
| 10538588 | Mesothelin-targeted chimeric antigen receptors and methods of making them | Prasad S. Adusumilli, Michel Sadelain, Yang Feng | 2020-01-21 |
| 10501539 | Compositions and methods for treating cancer with anti-CD19 immunotherapy | Dina Schneider, Rimas J. Orentas, Boro Dropulic, Zhongyu Zhu | 2019-12-10 |
| 10494435 | Human monoclonal antibodies specific for CD22 | Xiaodong Xiao, Ira H. Pastan | 2019-12-03 |
| 10472412 | Bispecific multivalent fusion proteins | Weizao Chen, Tianlei Ying | 2019-11-12 |
| 10434174 | Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2019-10-08 |